HomeKZR • NASDAQ
add
Kezar Life Sciences Inc
Previous close
$7.42
Day range
$7.37 - $7.49
Year range
$3.53 - $7.55
Market cap
54.55M USD
Avg Volume
70.02K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.25M | -41.42% |
Net income | -14.55M | 28.05% |
Net profit margin | — | — |
Earnings per share | -1.05 | 64.88% |
EBITDA | -8.15M | 61.76% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 71.88M | -45.65% |
Total assets | 76.65M | -47.02% |
Total liabilities | 6.57M | -76.32% |
Total equity | 70.07M | — |
Shares outstanding | 7.37M | — |
Price to book | 0.78 | — |
Return on assets | -23.88% | — |
Return on capital | -25.19% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -14.55M | 28.05% |
Cash from operations | -11.96M | 28.90% |
Cash from investing | 51.61M | 117.37% |
Cash from financing | -6.71M | -14,370.21% |
Net change in cash | 32.94M | 378.06% |
Free cash flow | -4.18M | 56.65% |
About
Founded
2015
Headquarters
Website
Employees
9
